PepsiCo (PEP) CFO Hugh Johnston says the food and snack manufacturer doesn't see Ozempic (Novo Nordisk) or other appetite suppressants impacting sales. He adds that the company is observing the trend, but does not believe that snacking is on the way out. Finally, he refers to the measures put in place by the Group to counter inflation. 
 
(MT Newswires)

Bloomberg videos